Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Clinical Chemistry
|
July 4, 2009
Monitoring therapeutic efficacy by real-time detection of Mycobacterium tuberculosis mRNA in sputum
Nino Mdivani, Haijing Li, Maka Akhalaia, et al.
Antimicrobial Agents and Chemotherapy
|
December 12, 2007
Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations
Medea Gegia, Nino Mdivani, Rodrigo E Mendes, et al.
The European Respiratory Journal
|
August 20, 2021
World Health Organization treatment outcome definitions for tuberculosis: 2021 update
Nguyen Nhat Linh, Kerri Viney, Medea Gegia, et al.
The European Respiratory Journal
|
June 27, 2020
Changes in treatment for multidrug-resistant tuberculosis according to national income
Nakwon Kwak, Nicholas Winters, Jonathon R Campbell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 7, 2023
Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis
Belén P Solans, Agathe Béranger, Kendra Radtke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 25, 2024
Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort Study
Hannah Morgan, Norbert Ndjeka, Tasnim Hasan, et al.
Bulletin of the World Health Organization
|
January 25, 2012
Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience
Jennifer Furin, Medea Gegia, Carole Mitnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 24, 2023
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis
Tasnim Hasan, Ellie Medcalf, Bern-Thomas Nyang'wa, et al.
Plos One
|
October 5, 2023
Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment
Nicholas Winters, Mireille E Schnitzer, Jonathon R Campbell, et al.
Emerging Infectious Diseases
|
February 22, 2019
Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis
Muhammad Osman, Elizabeth P Harausz, Anthony J Garcia-Prats, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Clinical Chemistry
|
July 4, 2009
Monitoring therapeutic efficacy by real-time detection of Mycobacterium tuberculosis mRNA in sputum
Nino Mdivani, Haijing Li, Maka Akhalaia, et al.
Antimicrobial Agents and Chemotherapy
|
December 12, 2007
Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations
Medea Gegia, Nino Mdivani, Rodrigo E Mendes, et al.
The European Respiratory Journal
|
August 20, 2021
World Health Organization treatment outcome definitions for tuberculosis: 2021 update
Nguyen Nhat Linh, Kerri Viney, Medea Gegia, et al.
The European Respiratory Journal
|
June 27, 2020
Changes in treatment for multidrug-resistant tuberculosis according to national income
Nakwon Kwak, Nicholas Winters, Jonathon R Campbell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 7, 2023
Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis
Belén P Solans, Agathe Béranger, Kendra Radtke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 25, 2024
Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort Study
Hannah Morgan, Norbert Ndjeka, Tasnim Hasan, et al.
Bulletin of the World Health Organization
|
January 25, 2012
Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience
Jennifer Furin, Medea Gegia, Carole Mitnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 24, 2023
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis
Tasnim Hasan, Ellie Medcalf, Bern-Thomas Nyang'wa, et al.
Plos One
|
October 5, 2023
Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment
Nicholas Winters, Mireille E Schnitzer, Jonathon R Campbell, et al.
Emerging Infectious Diseases
|
February 22, 2019
Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis
Muhammad Osman, Elizabeth P Harausz, Anthony J Garcia-Prats, et al.
Page
of 3